-
Inhibiting menin to treat myeloproliferative neoplasms shows preclinical promise
07/09/2026
Find how the blood cancers without effective treatments showed a selective vulnerability to the drug, providing a new potential therapeutic avenue to explore.
-
C1 neurons identified as a driver of prolonged fear and anxiety
07/09/2026
See how C1 neurons within the rostral ventrolateral medulla (RVLM) connect to periaqueductal grey matter and are activated under conditions prolonged anxiety.
-
Heather Currier Hunt to lead Leadership Development at St. Jude
06/29/2026
Heather Currier Hunt named senior vice president of the St. Jude Leadership Academy (SJLA). The 20-year learning expert will be tasked with evolving the SJLA into a world-class program.
-
St. Jude redesignated as WHO Collaborating Centre for Childhood Cancer
06/17/2026
Redesignation as the only WHO Collaborating Centre dedicated to pediatric cancer demonstrates shared commitment in advancing childhood cancer care together globally.
-
Study uncovers how cells identify and silence unwanted jumping genes
05/22/2026
See how cells prevent invading jumping gene transposon expression in fission yeast using RNA interference and heterochromatin to silence them.
-
Hidden small RNA determines if cholera bacterium can infect humans
05/14/2026
Learn how an RNA hiding mostly within another gene controls which environment Vibrio cholerae bacteria thrives in, which could improve prediction & prevention.
-
St. Jude researcher Hongbo Chi, PhD, elected to the National Academy of Sciences
05/04/2026
Learn why the National Academy of Sciences elected St. Jude immunologist Hongbo Chi, PhD, a leader in immunology and immunometabolism, to their membership.
-
Blood stem cells evade immunity in aplastic anemia by similar genetic mutations arising independently
05/01/2026
Explore new research showing that blood stem cells use multiple, independent mutations to escape autoimmunity, but these clones don’t increase cancer risk.
-
AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
04/29/2026
Learn a new strategy scientists used to find a low-toxicity, cross-tumor dependency as a proof of principle to find safer targets for cancer drug discovery.
-
Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder
04/22/2026
See how an antisense oligonucleotide reverses ultrarare X-linked genetic condition HNRNPH2-related neurodevelopmental disorder in preclinical study
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.